×
About 1,499,928 results

Michael J. Morris, MD, on Prostate Cancer: Impact of PSMA-Targeted Imaging on Clinical Management
https://ascopost.com/videos/asco20-virtual-scientific-program/michael-morris-on-the-impact-of-psma-targeted-imaging-on-clinical-management-of-prostate-cancer/

Jun 1st, 2020 - Michael J. Morris, MD, of Memorial Sloan Kettering Cancer Center, discusses phase III data from the CONDOR trial, which showed that PSMA-targeted PET scans detected and localized occult disease in most men with biochemically recurrent prostate cancer presenting with negative or equivocal conventional imaging findings (Abstract 5501).

PyL PET Tracer May Be Superior to Standard Imaging for Prostate Cancer
https://www.targetedonc.com/view/pyl-pet-tracer-may-be-superior-to-standard-imaging-for-prostate-cancer

May 30th, 2020 - PSMA-targeted 18F-DCFPyL-PET/CT imaging demonstrated excellent diagnostic performance in men with biochemically relapsed prostate cancer in terms of a correct localization rate that far exceeded the criteria to meet the primary end point, according to findings from the phase 3 CONDOR trial.

Diagnostic Performance of PSMA-Targeted PET Tracer Excels in Relapsed Prostate Cancer
https://www.onclive.com/conference-coverage/asco-2020/diagnostic-performance-of-psma-targeted-pet-tracer-excels-in-relapsed-prostate-cancer

May 30th, 2020 - Imaging with 18F-DCFPyL-PET/CT outperformed that of standard imaging modalities—such as bone scan, CT, MRI, and FDG PET—in patients with biochemically relapsed prostate cancer in the phase 3 CONDOR trial.

PSMA-Targeted PET Tracer Outperforms Standard Diagnostic Modalities in Relapsed Prostate Cancer
https://www.targetedonc.com/view/psma-targeted-pet-tracer-outperforms-standard-diagnostic-modalities-in-relapsed-prostate-cancer

May 30th, 2020 - 18F-DCFPyL-PET/CT imaging outperfomed standard imaging modalities, including bone scan, CT, MRI, and FDG PET, in patients with biochemically relapsed prostate cancer, according to the phase 3 CONDOR study.

18F-DCFPyL–PET/CT Imaging Improves Diagnostic Capability in Relapsed Prostate Cancer
https://dailynews.ascopubs.org/do/10.1200/ADN.20.200168/full/

May 29th, 2020 - Imaging with 18F-DCFPyL–PET/CT was found to be diagnostically effective, often guiding a change in treatment plan, in men with biochemically relapsed prostate cancer, according to the results of the phase III CONDOR study presented during the ASCO20 Virtual Scientific Program (Abstract 5501).

National Institute of Biomedical Imaging and Bioengineering (NIBIB)
https://www.nibib.nih.gov/

The mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is to improve health by leading the development and accelerating the application of biomedical technologies. The Institute is committed to integrating the physical and engineering sciences with the life sciences to advance basic research and medical care.

Improved Treatment Response Following Magnetic Resonance Imaging–Guided Focused Ultrasound for Lumbar Facet Joint Pain
https://www.sciencedirect.com/science/article/pii/S2542454819301535

Magnetic resonance imaging–guided focused ultrasound (MRgFUS) is a noninvasive modality that allows for precise tissue ablation with sparing of surrounding structures. Early reports of the use of MRgFUS for the treatment of facet joint osteoarthritis are promising. We present a case of facet joint pain treated successfully by MRgFUS at our institution. Magnetic resonance imaging–guided focused ...

Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection
https://jamanetwork.com/journals/jamacardiology/fullarticle/2770645

Myocarditis is a significant cause of sudden cardiac death in competitive athletes and can occur with normal ventricular function.1 Recent studies have raised concerns of myocardial inflammation after recovery from coronavirus disease 2019 (COVID-19), even in asymptomatic or mildly symptomatic patients.2 Our objective was to investigate the use of cardiac magnetic resonance (CMR) imaging in com...

Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033758/

Levodopa-induced dyskinesia (LID) is the most common, disruptive complication of Parkinson’s disease (PD) pharmacotherapy, yet despite decades of research, the changes in regional brain function underlying LID remain largely unknown. We previously found that the cerebral vasomotor and metabolic responses to levodopa are dissociated in PD subjects. Nonetheless, it is unclear whether levodopa-med...

The serotonergic system in Parkinson’s patients with dyskinesia: evidence from imaging studies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060863/

The purpose of review is to review the current status of positron emission tomography (PET) molecular imaging of serotonergic system in Parkinson’s patients who experience levodopa-induced (LIDs) and graft-induced dyskinesias (GIDs). PET imaging studies have shown that Parkinson’s disease is characterized by progressive loss of dopaminergic and serotonergic neurons. Parkinson’s patients who exp...

Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort
https://www.nature.com/articles/s41531-018-0069-x
NPJ Parkinson's Disease;

Levodopa-induced dyskinesias (LID) negatively impact on the quality of life of patients with Parkinson’s disease (PD). We assessed the risk factors for LID in a cohort of de-novo PD patients enrolled in the Parkinson’s Progression Markers Initiative (PPMI). This retrospective cohort study included all PD patients enrolled in the PPMI cohort. Main outcome was the incidence rate of dyskinesia, de...

Imaging in Parkinson’s disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280219/
Clinical Medicine;

The clinical presentation of Parkinson’s disease (PD) is heterogeneous and overlaps with other conditions, including the parkinsonian variant of multiple system atrophy (MSA-P), progressive supranuclear palsy (PSP) and essential tremor. Imaging of the brain in patients with parkinsonism has the ability to increase the accuracy of differential diagnosis. Magnetic resonance imaging (MRI), single ...

Dopamine Transporter Density in de novo Parkinson's Disease Does Not Relate to the Development of Levodopa-Induced Dyskinesias
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901354/

In Parkinson’s disease (PD), the onset of levodopa-induced dyskinesias (LIDs) is difficult to predict. This study examines whether dopamine transporter (DAT)-specific SPECT imaging in de novo PD relates to later development of LIDs.

Alcohol Intoxication and Cognition: Implications on Mechanisms and Therapeutic Strategies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029710/

Binge alcohol drinking is highly prevalent in young adults and results in 30% deaths per year in young males. Binge alcohol drinking or acute alcohol intoxication is a risk factor for developing alcohol use disorder (AUD). Three FDA approved drugs are currently in use as therapy for AUD; however, all of them have contra-indications and limitations. Structural brain imaging studies in alcoholics...

Brain imaging before and after COVID-19 in UK Biobank
https://www.medrxiv.org/content/10.1101/2021.06.11.21258690v1.full.pdf
Medrxiv Douaud G, Lee S et. al.

Jun 14th, 2021 - There is strong evidence for brain-related pathologies in COVID-19, some of which could be a consequence of viral neurotropism. The vast majority of brain imaging studies so far have focused on qualitative, gross pathology of moderate to severe cases, often carried out on hospitalised patients.

Highlighting COVID-19 Blood Clot Dangers
https://www.uspharmacist.com/article/highlighting-covid19-blood-clot-dangers

Based on recent reports that demonstrated a strong association between elevated D-dimer levels and poor prognosis, concerns have risen about thrombotic complications in patients with COVID-19. To address these concerns, the National Institute for Public Health of the Netherlands asked a group of radiology and vascular medicine experts to provide guidance for the imaging workup and treatment of ...

Changes of 18FFDG-PET/CT quantitative parameters in tumor lesions by the Bayesian penal...
https://doi.org/10.1186/s12880-021-00664-7 10.2967/jnumed.115.159301 10.1088/0031-9155/51/15/R01 10.1088/0031-9155/60/15/5733 10.1016/j.ejrad.2015.06.025 10.1007/s00330-015-3832-y 10.1007/s00330-016-4253-2 10.2214/AJR.18.20478 10.1007/s00259-014-2961-x 10.2967/jnumed.116.185561 10.1186/s13550-019-0512-y 10.1007/s13139-019-00594-x 10.1016/j.ejrad.2019.06.005 10.1016/j.ejmp.2018.02.013 10.2967/jnumed.106.035774 10.1186/1748-717X-9-41 10.1111/1471-0528.12543 10.2967/jnumed.111.099531 10.1016/j.compbiomed.2014.04.014 10.1007/s10278-018-00173-0 10.1002/ima.22154 10.1016/j.compbiomed.2020.103701 10.1186/s40658-020-0270-y
BMC Medical Imaging; Liu Y, Gao MJ et. al.

Sep 18th, 2021 - To compare the changes in quantitative parameters and the size and degree of 18F-fluorodeoxyglucose ([18F]FDG) uptake of malignant tumor lesions between Bayesian penalized-likelihood (BPL) and non-BPL reconstruction algorithms. Positron emission tomography/computed tomography images of 86 malignant tumor lesions were reconstructed using the algorithms of ordered subset expectation maximization ...

18F-FDG PET/CT predicts acute exacerbation in idiopathic pulmonary fibrosis after thora...
https://doi.org/10.1186/s12890-021-01659-4 10.1164/rccm.2009-040GL 10.1002/jso.10145 10.1016/j.ejcts.2007.02.035 10.1055/s-2007-965645 10.1016/j.jtcvs.2008.07.016 10.1016/S0022-5223(03)00028-X 10.1016/S0022-5223(03)00791-8 10.2169/internalmedicine.48.1650 10.1093/ejcts/ezs147 10.1093/icvts/ivr029 10.1378/chest.104.4.997 10.1378/chest.12-1359 10.1097/MNM.0000000000000083 10.2967/jnumed.116.174946 10.1186/s41824-018-0045-z 10.1186/s12931-017-0556-3 10.1183/09031936.05.00035005 10.1183/09031936.05.00034805 10.1183/09031936.05.00034905 10.7326/0003-4819-156-10-201205150-00004 10.1164/rccm.201604-0801CI 10.1016/0021-9681(87)90171-8 10.1007/s12149-018-1273-9 10.1007/s12149-013-0730-8 10.1007/s00259-011-1906-x 10.1186/s12931-016-0400-1 10.1111/resp.13075 10.1016/j.athoracsur.2011.06.055 10.3892/mco.2016.954 10.1007/s00595-010-4384-z 10.1016/j.jtcvs.2013.09.050
BMC Pulmonary Medicine; Yoon HY, Lee SH et. al.

Sep 18th, 2021 - Acute exacerbation (AE) is the most lethal postoperative complication in idiopathic pulmonary fibrosis (IPF); however, prediction before surgery is difficult. We investigated the role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in predicting postoperative AE in IPF. Clinical data of 48 IPF patients who underwent 18F-FDG PET/CT before thoracic surg...

Neural network-based left ventricle geometry prediction from CMR images with applicatio...
https://doi.org/10.1016/j.artmed.2021.102140
Artificial Intelligence in Medicine; Romaszko L, Borowska A et. al.

Sep 18th, 2021 - Combining biomechanical modelling of left ventricular (LV) function and dysfunction with cardiac magnetic resonance (CMR) imaging has the potential to improve the prognosis of patient-specific cardiovascular disease risks. Biomechanical studies of LV function in three dimensions usually rely on a computerized representation of the LV geometry based on finite element discretization, which is ess...

Optical Coherence Tomography of Plaque Vulnerability and Rupture: JACC Focus Seminar Pa...
https://doi.org/10.1016/j.jacc.2021.06.050
Journal of the American College of Cardiology; Aguirre AD, Arbab-Zadeh A et. al.

Sep 18th, 2021 - Plaque rupture is the most common cause of acute coronary syndromes and sudden cardiac death. Characteristics and pathobiology of vulnerable plaques prone to plaque rupture have been studied extensively over 2 decades in humans using optical coherence tomography (OCT), an intravascular imaging technique with micron scale resolution. OCT studies have identified key features of plaque vulnerabili...